Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Men with hair loss often have abnormal cholesterol levels, so early screening is advised.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Men with male pattern baldness have higher uric acid levels, which can decrease with finasteride treatment.

Combining platelet-rich plasma with other treatments may improve hair growth in people with hair loss, but more research is needed.

Microneedling therapy is effective and safe for treating hair disorders worsened by COVID-19.

Some nutritional supplements may help thicken hair in people with hair loss, but taking too much can cause side effects.

Stem cell therapies show promise for hair regrowth but need more research to confirm effectiveness.

PRP may help with hair loss and improve hair quality with few side effects, but more research is needed.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

In Pakistan, men with more severe hair loss often have a higher BMI.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

People with hair loss have low zinc levels; zinc supplements and laser therapy may help.

The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.

Men with higher body mass index (BMI) in Taiwan tend to have more severe hair loss.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Lifestyle factors like frequent shampooing and mental labor are linked to androgenetic alopecia.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Smoking and lighter hair color increase alopecia risk, especially in women and those over 25.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

High TNF-α levels may increase hair loss risk after PRP therapy.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Telogen effluvium is the most common hair loss in women, often linked to low iron, while tight hairstyles and headscarves increase traction alopecia risk.

PRP might help with hair growth, but the evidence is weak.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.